33 Stocks Moving In Tuesday's Mid-Day Session

Gainers

• HCW Biologics Inc. HCWB surged 31% to $3.75.
• Kaival Brands Innovations Group, Inc. KAVL jumped 28.9% to $2.0750 after surging 18% on Monday. Kaival Brands Innovations recently announced plans to launch distribution of its products in the U.K.
• Full Truck Alliance Co. Ltd. YMM rose 15% to $16.54.
• iQIYI, Inc. IQ shares gained 13.5% to $9.65.
• InflaRx N.V. IFRX shares climbed 13.2% to $2.7387 after the company announced it was awarded an up to roughly $50.7 million grant by the German government to advance the development of vilobelimab for the treatment of severe COVID-19.
• Harmony Biosciences Holdings, Inc. HRMY gained 12.8% to $42.89 after it was announced the company will replace Retail Properties of America in the S&P SmallCap 600.
• Ginkgo Bioworks Holdings, Inc. DNA surged 12.2% to $13.83.
• AlloVir, Inc. ALVR jumped 11.6% to $23.30.
• Socket Mobile, Inc. SCKT rose 11.3% to $8.30.
• Prelude Therapeutics Incorporated PRLD climbed 11.2% to $17.48.
• ViewRay, Inc. VRAY gained 11% to $6.62.
• X Financial XYF surged 10.5% to $4.9650.
• Skylight Health Group Inc. SLHG gained 10.5% to $3.4046.
• Youdao, Inc. DAO gained 9.6% to $13.14.
• Athene Holding Ltd. ATH jumped 9.5% to $84.09.
• Zix Corporation ZIXI rose 6% to $8.12 after Reuters reported that the company is exploring a sale.

Check out these big penny stock gainers and losers

Losers

• Galera Therapeutics, Inc. GRTX shares dipped 68.1% to $2.3592 in reaction to disappointing data from the Phase 3 ROMAN trial of avasopasem manganese in severe oral mucositis (SOM) patients with locally advanced head and neck cancer (HNC) undergoing standard-of-care radiotherapy.
• Atea Pharmaceuticals, Inc. AVIR fell 62% to $15.451 after the company reported data from the Phase 2 MOONSONG trial of AT-527 in the outpatient setting in patients with mild or moderate COVID-19. The trial did not meet the primary endpoint of clear reduction in SARS-CoV-2 viral load in the overall population compared to placebo.
• Peabody Energy Corporation BTU dipped 17% to $16.34. Peabody recently said it sees preliminary Q3 sales of $670 million to $690 million.
• Windtree Therapeutics, Inc. WINT fell 16% to $1.89.
• EverQuote, Inc. EVER dropped 16% to $14.56 after the company cut third-quarter sales guidance below estimates.
• Aerovate Therapeutics, Inc. AVTE declined 13.4% to $14.62.
• Communications Systems, Inc. JCS dropped 12.7% to $4.4650.
• Zymergen Inc. ZY fell 12.3% to $11.07.
• TaskUs, Inc. TASK fell 12.3% to $63.95 after the company announced the launch of a secondary offering of 10 million shares of Class A common stock.
• CONSOL Energy Inc. CEIX dipped 11.8% to $31.49.
• Remitly Global, Inc. RELY fell 11% to $36.02.
• Oyster Point Pharma, Inc. OYST fell 10.5% to $12.41. The FDA recently approved Oyster Point Pharma Tyrvaya (varenicline solution) Nasal Spray 0.03 mg for signs and symptoms of dry eye disease.
• Valneva SE VALN shares fell 10.4% to $35.12. Valneva shares jumped around 40% on Monday after the company reported VLA2001 met both co-primary endpoints in the Phase 3 pivotal trial Cov-Compare.
• DLocal Limited DLO dropped 10% to $54.53 after the company announced a proposed secondary offering and issued Q3 preliminary results.
• ESS Tech, Inc. GWH fell 8.6% to $17.05.
• Aehr Test Systems AEHR dropped 7.8% to $20.25.
• Tata Motors Limited TTM shares fell 5.7% to $31.86. Tata Motors recently raised $1 billion in investments from TPG Rise Climate and ADQ for its Passenger Electric Vehicle business. The company also reported a year-over-year increase in global wholesales.